These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2004-005020-41 Topische Anwendung von Tacrolimus (Protopic) bei verschiedenen Formen des kutanen Lupus erythe-matodes im Rahmen einer klinischen Untersuchung an mehreren nationalen Zentren 2008-06-30 due-trials
Completed, but no date, and reported results 2005-004051-35 Intramyocardial Application of Stem Cells in combination with transmyocardial Laser Revascularisation (TMLR) in CABG Patients bad-data
Reported results 2005-004454-27 Klinische Phase II-Prüfung zur Bestimmung von Wirksamkeit und Verträglichkeit der Kombination von 5-Azacytidin und Valproinsäure bei Personen mit MDS und anderen myeloischen Neoplasien, bei denen eine... 2009-07-31 due-trials
Reported results 2006-000504-17 Konsekutive Aderlass- und Peginterferon alfa-2a -Ribavirin-Standardtherapie im Vergleich zu einer Peginterferon alfa-2a-Ribavirin-Standardtherapie bei naiven Patienten mit HCV Genotyp 1 und Ferritin >... 2010-09-06 due-trials
Reported results 2006-003122-28 Argatroban versus Lepirudin in Critically Ill Patients 2012-03-31 due-trials
Completed, but no date, and reported results Terminated 2006-005296-18 Einsatz von Haemateâ HS bei Patienten mit schweren Blutungskomplikationen bei Herzklappenersatz wegen Aortenstenose HAVAS-Studie (Haemate HS in patients with severe bleeding undergoing valve replace... bad-data
Reported results Terminated 2007-000730-40 Phase II study evaluating transarterial chemoembolization (TACE) in combination with sorafenib for the treatment of advanced hepatocellular carcinoma (HCC) 2010-09-15 due-trials
Reported results 2007-002659-17 Multicenter, open-label phase II trial on post-surgery chemoradiation in combination with cetuximab in squamous cell carcinoma of the head and neck with high risk of locoregional recurrence. 2013-07-09 due-trials
Reported results 2013-000577-77 EARLY ORAL SWITCH THERAPY IN LOW-RISK STAPHYLOCOCCUS AUREUS BLOODSTREAM INFECTION ACRONYM: SABATO (Staphylococcus aureus Bacteremia Antibiotic Treatment Options) 2020-03-31 due-trials
Completed, but no date Terminated 2013-004604-19 Delayed Gadolinium-enhanced Magnetic resonance Imaging (MRI) of Cartilage - A pilot study to measure the effect of Adalimumab plus Methotrexat (MTX) versus Placebo plus MTX on cartilage in early rheum... bad-data
Ongoing 2017-000304-14 Phase II trial of vaccination with lysate-loaded, mature dendritic cells integrated into standard radiochemotherapy in newly diagnosed glioblastoma Phase II Studie zur Vakzinierung mit lysat-bela... not-yet-due
Completed, report not yet due 2018-002936-26 Efficacy and safety of Trifluridine/Tipiracil in combination with Irinotecan as a second line therapy in patients with Cholangiocarcinoma 2024-01-08 not-yet-due
Ongoing 2019-001416-30 IDH2-Post-Allo-Trial: Enasidenib as consolidation or salvage therapy for patients with IDH2 mutated AML or MDS following allogeneic blood stem cell transplantation IDH2-Post-Allo-Trial: Enasideni... not-yet-due
Not reported 2020-004695-18 Reconvalescent plasma/Camostat mesylate early in Sars-CoV-2 Q-PCR positive high risk individuals Rekonvaleszenten Plasma / Camostat mesylat bei Sars-CoV-2 Q-PCR-positiven Personen mit hohem Risiko ... 2021-10-29 due-trials
Ongoing 2022-002435-66 Phase-I/II trial to assess the safety and efficacy of Venetoclax in addition to sequential conditioning with Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for allogeneic blood stem cell transp... not-yet-due